149 related articles for article (PubMed ID: 14753595)
1. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.
Bechtold RE; Chen MY; Stanton CA; Savage PD; Levine EA
Abdom Imaging; 2003; 28(6):808-14. PubMed ID: 14753595
[TBL] [Abstract][Full Text] [Related]
2. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
Vanel D; Albiter M; Shapeero L; Le Cesne A; Bonvalot S; Le Pechoux C; Terrier P; Petrow P; Caillet H; Dromain C
Eur J Radiol; 2005 Apr; 54(1):118-23. PubMed ID: 15797301
[TBL] [Abstract][Full Text] [Related]
3. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib.
Kim HC; Lee JM; Choi SH; Han H; Kim SS; Lee SH; Han JK; Choi BI
Korean J Radiol; 2004; 5(3):157-63. PubMed ID: 15467412
[TBL] [Abstract][Full Text] [Related]
4. Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate).
Chen MY; Bechtold RE; Savage PD
AJR Am J Roentgenol; 2002 Oct; 179(4):1059-62. PubMed ID: 12239065
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors: CT and MRI findings.
Sandrasegaran K; Rajesh A; Rushing DA; Rydberg J; Akisik FM; Henley JD
Eur Radiol; 2005 Jul; 15(7):1407-14. PubMed ID: 15761716
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).
Mabille M; Vanel D; Albiter M; Le Cesne A; Bonvalot S; Le Péchoux C; Terrier P; Shapeero LG; Dromain C
Eur J Radiol; 2009 Feb; 69(2):204-8. PubMed ID: 19046841
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
Scaife CL; Hunt KK; Patel SR; Benjamin RS; Burgess MA; Chen LL; Trent J; Raymond AK; Cormier JN; Pisters PW; Pollock RE; Feig BW
Am J Surg; 2003 Dec; 186(6):665-9. PubMed ID: 14672776
[TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
[TBL] [Abstract][Full Text] [Related]
9. [A patient with unresectable gastrointestinal stromal tumor responded to STI571].
Sagawa C; Koide H; Ito T; Fuchigami M; Nishiyama R; Kobayashi S; Takekawa Y; Murata A; Arakawa Y
Nihon Shokakibyo Gakkai Zasshi; 2004 Apr; 101(4):382-8. PubMed ID: 15114834
[No Abstract] [Full Text] [Related]
10. F-18 FDG PET imaging in gastrointestinal stromal tumor.
Reddy MP; Reddy P; Lilien DL
Clin Nucl Med; 2003 Aug; 28(8):677-9. PubMed ID: 12897659
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.
Bauer S; Hagen V; Pielken HJ; Bojko P; Seeber S; Schütte J
Anticancer Drugs; 2002 Sep; 13(8):847-9. PubMed ID: 12394270
[TBL] [Abstract][Full Text] [Related]
12. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
[TBL] [Abstract][Full Text] [Related]
13. Giant malignant gastrointestinal stromal tumors: recurrence and effects of treatment with STI-571.
Chen TW; Liu HD; Shyu RY; Yu JC; Shih ML; Chang TM; Hsieh CB
World J Gastroenterol; 2005 Jan; 11(2):260-3. PubMed ID: 15633227
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography and sonographic findings of hepatic metastases from gastrointestinal stromal tumors after chemotherapy.
Yang DM; Kim H; Kang JH; Park CH; Kim HS; Shin DB
J Comput Assist Tomogr; 2005; 29(5):592-5. PubMed ID: 16163025
[TBL] [Abstract][Full Text] [Related]
16. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
[TBL] [Abstract][Full Text] [Related]
17. Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors.
Schlemmer M; Schinwald N; Bruns C; Berger F; Reichardt P
J Gastrointest Cancer; 2012 Jun; 43(2):385-7. PubMed ID: 20922581
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.
De Giorgi U; Aliberti C; Benea G; Conti M; Marangolo M
Clin Cancer Res; 2005 Sep; 11(17):6171-6. PubMed ID: 16144917
[TBL] [Abstract][Full Text] [Related]
19. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of gastrointestinal stromal tumours: a single centre experience during the past 17 years.
De Vogelaere K; Van De Winkel N; Aerts M; Haentjens P; Spitali C; Van Loo I; Delvaux G
Acta Chir Belg; 2014; 114(3):167-73. PubMed ID: 25102705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]